This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Updated Feb. 9, 2022 8:14 am ET / Original Feb. 9, 2022 4:51 am ET
- Order Reprints
- Print Article
GlaxoSmithKline said it expects profit to rise in 2022 and said it remained on track to spin off its consumer healthcare arm by the middle of the year.
The U.K. drugmaker also beat earnings expectations in the fourth quarter.
Glaxo (ticker: GSK) said sales in 2022 after the spinoff of the consumer arm were expected to rise between 5% to 7%,...